🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to measure the relative "barrier" function of ...
Status
Completed
Location
Southern California College of Optometry
Start Date
2007-09
Trial ID
NCT00560898
Treatments Being Tested
Prospective study to investigate the correlation between CD39/CD73 expressi...
Status
Completed
Location
Service de Rhumatologie, Centre Hospitalier Lyon-Sud (HCL)
Start Date
2016-09
Trial ID
NCT03953378
Treatments Being Tested
Endometrial carcinoma is the most common gynecologic cancer in the western ...
Status
Unknown
Location
Jersey city medical center
Start Date
2020-08-25
Trial ID
NCT04528940
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2007-01
Trial ID
NCT00470535
Treatments Being Tested
RATIONALE: Azadirachta indica may be an effective treatment for chronic lym...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01251250
RATIONALE: Celecoxib may stop the growth of tumor cells by blocking some of...
Status
Unknown
Location
Centre Hospitalier Universitaire Vaudois
Start Date
2006-06
Trial ID
NCT00357617
This study was to test an optimal concentration of Lugol's solution which c...
Status
Completed
Location
Qilu Hospital, Shandong University
Start Date
2017-09-01
Trial ID
NCT03180944
RATIONALE: Laboratory-treated T cells may be able to kill tumor cells when ...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2007-09
Trial ID
NCT00553306
RATIONALE: Studying samples of tissue and bone marrow from patients with ca...
Status
Completed
Location
Multiple Locations
Start Date
2011-05
Trial ID
NCT01358604
RATIONALE: Giving thalidomide together with prednisone and cyclophosphamide...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00445900